homefeedbacksupportlog on 6-Jul-2008 
  About F1000

 What is F1000 Biology?
 Key features
 How it's organized
 FAQs
 Faculties and sections
 Scope of sections
 List of Faculty Members
 The evaluation system
 Citing F1000
 Take a tour of the site
 Accessing fulltexts
 PubMed linkout
 How to subscribe
 Academic subscriptions
 Corporate subscriptions
 Try F1000 for free
 Who we are
 Media information
 Librarian resources
 Press releases
 In the press
 Developing countries
 F1000 Medicine
 Terms and conditions
 Privacy policy
 Contact us


Richard Harland
Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States of America

Head of Faculty: DEVELOPMENTAL BIOLOGY [ since 12 September 2001 ]
[ Biography ] [ Homepage ]
Biography

Research Interests
The objective of our work is to understand early vertebrate development at the molecular level. We study this problem in both the amphibian Xenopus, and in the mouse. Xenopus embryos are large and easily manipulated, so that the function of various macromolecules, such as RNA and protein, can be assayed by microinjection into living embryos. Functional assays in Xenopus can then be complemented by genetic knockouts in the mouse, to gain fuller understanding of the normal requirements for gene action in the developing embryo.

Current Projects
Axis formation and Neural induction: Pattern formation in vertebrate embryos proceeds by a series of cell-cell interactions, or inductions. These inductions activate signal transduction pathways to change gene expression. The embryo is very sensitive to small changes in signaling, so that interesting bioactivities can be detected by their effects on embryonic phenotype. Starting with cDNA libraries made from embryos, we inject synthetic mRNA from small pools of library, and assay either embryo morphology or gene expression. Such functional assays allow us to find genes that we can then study to understand the molecular basis for embryonic inductions.

These screens have isolated various molecules that participate in embryonic signaling. Some encode secreted proteins, that either bind to receptors and activate signal transduction pathways, while some block the activity of other signaling molecules. One such molecule, Noggin, can act as a direct neural inducer, and illustrates the principle that blocking a signal can be as informative to cell fate as activating a pathway. Noggin and other similar molecules interact with yet other signals to produce the full range of neural cell types.

While there is an overall understanding of signaling pathways that contribute to formation of the mesoderm and neural plate, there are many aspects of neural and mesodermal patterning that remain poorly understood. Current projects include examination of signaling from the neural plate to the mesoderm, screens for molecules that affect anterior-posterior organization of the neural plate, and screens for new molecules involved in mesoderm induction and patterning.

A crucial aspect of axis formation is the coordinated movement of cells during gastrulation. The development of fluorescent protein fusions to mark cytoskeletal and cell surface changes will allow the functional dissection of this process. We have shown that the coordination of cell movements during convergence and extension of the Xenopus gastrula relies on a conserved Wnt signaling pathway, the planar cell polarity pathway.

Mouse development: While Xenopus is extremely useful for embryology, it is not suited to genetic experiments. To complement the Xenopus embryology, we make mutations in mouse homologs of genes that we isolate. Thus we can not only study the activity of genes in Xenopus, but also analyze the requirement for the gene rigorously in the mouse. For example, noggin is expressed in several places in the mouse, and we find that noggin function is required for correct nervous system, somite and skeletal development. Noggin expression and function overlaps with that of other BMP antagonists, and we are in the process of analyzing mutations in other antagonists, individually and in combination with the noggin mutation.

Home page

http://mcb.berkeley.edu/faculty/GEN/harlandr.html



© 1999-2008 Biology Reports Ltd unless otherwise stated < info@f1000.com >   Terms and conditions   Legal info